Dr. Althea 345 Relief Cream contains a potent blend of Niacinamide and plant extracts to reduce dark spots and blemishes. It also promotes an even skin tone, assisting you in achieving clearer and more radiant skin.
The multi-layered cream structure formulated with Ceramide NP and Hyaluronic acids help restore dull skin while delivering nutrients deeply into the skin to provide continuous care by locking in moisture and nutrients.
It cares for sensitive skin and red blemishes caused by external factors with Beta-glucan, Panthenol, and Plant extracts. These calming ingredients can quickly help soothe your skin effectively by providing moisture.
Dr Althea 345 Relief Cream offers a moisturizing texture with a silky finish without any greasy feeling. Its refreshing formula is ideal for any time as part of your post-acne skincare routine.
How to use it?
- Wash your face with a gentle cleanser suited for your skin type.
- Apply less viscous skincare products like toner first.
- Apply an adequate amount of the 345 Barrier Cream as your final or semi-final step in your skincare routine.
INGREDIENTS:
WATER, PROPANEDIOL, GLYCERIN, CYCLOHEXASILOXANE, 1,2-HEXANEDIOL, NIACINAMIDE, CAPRYLIC/CAPRIC, TRIGLYCERIDE, POLYGLYCERIN-3, PANTHENOL, POLYGLYCERYL-10 STEARATE, HYDROGENATED POLYDECENE, HYDROGENATED POLY(C6-14 OLEFIN), DICAPRYLYL CARBONATE, AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER, C14-22 ALCOHOLS, POLYMETHYLSILSESQUIOXANE, C12-20 ALKYL GLUCOSIDE, BUTYLENE GLYCOL, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, ETHYLHEXYLGLYCERIN, POLYQUATERNIUM-51, TROMETHAMINE, SODIUM HYALURONATE, COPTIS JAPONICA ROOT EXTRACT, HOUTTUYNIA CORDATA EXTRACT, OENOTHERA BIENNIS (EVENING PRIMROSE) FLOWER EXTRACT, BETA-GLUCAN, RESVERATROL, GARDENIA FLORIDA FRUIT EXTRACT, LAVANDULA ANGUSTIFOLIA (LAVENDER) FLOWER EXTRACT, OPUNTIA FICUS-INDICA STEM EXTRACT, HYDROLYZED HYALURONIC ACID, CENTELLA ASIATICA LEAF EXTRACT, PHENOXYETHANOL, HIBISCUS SABDARIFFA FLOWER EXTRACT, TOCOPHEROL, CORALLINA OFFICINALIS EXTRACT, CERAMIDE NP
Reviews
There are no reviews yet.